ID   1433B_MOUSE             Reviewed;         246 AA.
AC   Q9CQV8; O70455; Q3TY33; Q3UAN6;
DT   26-SEP-2001, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   10-APR-2019, entry version 176.
DE   RecName: Full=14-3-3 protein beta/alpha;
DE   AltName: Full=Protein kinase C inhibitor protein 1;
DE            Short=KCIP-1;
DE   Contains:
DE     RecName: Full=14-3-3 protein beta/alpha, N-terminally processed;
GN   Name=Ywhab;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=C57BL/6J;
RA   Karpitskiy V.V., Shaw A.S.;
RL   Submitted (APR-1998) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J;
RC   TISSUE=Bone marrow, Embryo, Kidney, Liver, Thymus, and Visual cortex;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   PROTEIN SEQUENCE OF 1-12; 14-57; 61-70; 84-117; 128-169; 196-246 AND
RP   215-224, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=C57BL/6J, and OF1; TISSUE=Brain, and Hippocampus;
RA   Lubec G., Kang S.U., Sunyer B., Chen W.-Q.;
RL   Submitted (JAN-2009) to UniProtKB.
RN   [4]
RP   PHOSPHORYLATION AT SER-60.
RX   PubMed=9705322; DOI=10.1074/jbc.273.34.21834;
RA   Megidish T., Cooper J., Zhang L., Fu H., Hakomori S.;
RT   "A novel sphingosine-dependent protein kinase (SDK1) specifically
RT   phosphorylates certain isoforms of 14-3-3 protein.";
RL   J. Biol. Chem. 273:21834-21845(1998).
RN   [5]
RP   INTERACTION WITH SYNPO2.
RX   PubMed=15883195; DOI=10.1083/jcb.200411169;
RA   Faul C., Huettelmaier S., Oh J., Hachet V., Singer R.H., Mundel P.;
RT   "Promotion of importin alpha-mediated nuclear import by the
RT   phosphorylation-dependent binding of cargo protein to 14-3-3.";
RL   J. Cell Biol. 169:415-424(2005).
RN   [6]
RP   INTERACTION WITH PRKCE.
RX   PubMed=18604201; DOI=10.1038/ncb1749;
RA   Saurin A.T., Durgan J., Cameron A.J., Faisal A., Marber M.S., Parker P.J.;
RT   "The regulated assembly of a PKCepsilon complex controls the completion of
RT   cytokinesis.";
RL   Nat. Cell Biol. 10:891-901(2008).
RN   [7]
RP   NITRATION [LARGE SCALE ANALYSIS] AT TYR-84 AND TYR-106, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=16800626; DOI=10.1021/bi060474w;
RA   Sacksteder C.A., Qian W.J., Knyushko T.V., Wang H., Chin M.H., Lacan G.,
RA   Melega W.P., Camp D.G., Smith R.D., Smith D.J., Squier T.C., Bigelow D.J.;
RT   "Endogenously nitrated proteins in mouse brain: links to neurodegenerative
RT   disease.";
RL   Biochemistry 45:8009-8022(2006).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung,
RC   Pancreas, Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [9]
RP   INTERACTION WITH SAMSN1.
RX   PubMed=20478393; DOI=10.1016/j.biocel.2010.05.004;
RA   Brandt S., Ellwanger K., Beuter-Gunia C., Schuster M., Hausser A.,
RA   Schmitz I., Beer-Hammer S.;
RT   "SLy2 targets the nuclear SAP30/HDAC1 complex.";
RL   Int. J. Biochem. Cell Biol. 42:1472-1481(2010).
RN   [10]
RP   INTERACTION WITH DAPK2.
RX   PubMed=26047703; DOI=10.1016/j.bbrc.2015.05.105;
RA   Yuasa K., Ota R., Matsuda S., Isshiki K., Inoue M., Tsuji A.;
RT   "Suppression of death-associated protein kinase 2 by interaction with 14-3-
RT   3 proteins.";
RL   Biochem. Biophys. Res. Commun. 464:70-75(2015).
CC   -!- FUNCTION: Adapter protein implicated in the regulation of a large
CC       spectrum of both general and specialized signaling pathways. Binds to a
CC       large number of partners, usually by recognition of a phosphoserine or
CC       phosphothreonine motif. Binding generally results in the modulation of
CC       the activity of the binding partner. Negative regulator of
CC       osteogenesis. Blocks the nuclear translocation of the phosphorylated
CC       form (by AKT1) of SRPK2 and antagonizes its stimulatory effect on
CC       cyclin D1 expression resulting in blockage of neuronal apoptosis
CC       elicited by SRPK2. Negative regulator of signaling cascades that
CC       mediate activation of MAP kinases via AKAP13.
CC       {ECO:0000250|UniProtKB:P31946}.
CC   -!- SUBUNIT: Homodimer (By similarity). Interacts with SAMSN1 and PRKCE
CC       (PubMed:18604201, PubMed:20478393). Interacts with AKAP13. Interacts
CC       with SSH1 and TORC2/CRTC2. Interacts with ABL1; the interaction results
CC       in cytoplasmic location of ABL1 and inhibition of cABL-mediated
CC       apoptosis. Interacts with ROR2 (dimer); the interaction results in
CC       phosphorylation of YWHAB on tyrosine residues. Interacts with GAB2.
CC       Interacts with YAP1 (phosphorylated form). Interacts with the
CC       phosphorylated (by AKT1) form of SRPK2. Interacts with PKA-
CC       phosphorylated AANAT. Interacts with MYO1C. Interacts with SIRT2 (By
CC       similarity). Interacts with the 'Thr-369' phosphorylated form of DAPK2
CC       (PubMed:26047703). Interacts with PI4KB, TBC1D22A and TBC1D22B.
CC       Interacts with the 'Ser-1134' and 'Ser-1161' phosphorylated form of
CC       SOS1 (By similarity). Interacts (via phosphorylated form) with YWHAB;
CC       this interaction occurs in a protein kinase AKT1-dependent manner (By
CC       similarity). Interacts with SLITRK1 (By similarity). Interacts with
CC       SYNPO2 (phosphorylated form); YWHAB competes with ACTN2 for interaction
CC       with SYNPO2 (PubMed:15883195). Interacts with RIPOR2 (via
CC       phosphorylated form); this interaction occurs in a chemokine-dependent
CC       manner and does not compete for binding of RIPOR2 with RHOA nor blocks
CC       inhibition of RIPOR2-mediated RHOA activity (By similarity).
CC       {ECO:0000250|UniProtKB:P31946, ECO:0000269|PubMed:15883195,
CC       ECO:0000269|PubMed:18604201, ECO:0000269|PubMed:20478393,
CC       ECO:0000269|PubMed:26047703}.
CC   -!- INTERACTION:
CC       Q5S006:Lrrk2; NbExp=3; IntAct=EBI-771608, EBI-2693710;
CC       P16054:Prkce; NbExp=6; IntAct=EBI-771608, EBI-298451;
CC       Q91YE8:Synpo2; NbExp=3; IntAct=EBI-771608, EBI-7623057;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P31946}.
CC       Melanosome {ECO:0000250|UniProtKB:P31946}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative initiation; Named isoforms=2;
CC       Name=Long;
CC         IsoId=Q9CQV8-1; Sequence=Displayed;
CC       Name=Short;
CC         IsoId=Q9CQV8-2; Sequence=VSP_018634;
CC         Note=No experimental confirmation available. Contains a N-
CC         acetylmethionine at position 1. {ECO:0000250};
CC   -!- PTM: Isoform alpha differs from isoform beta in being phosphorylated
CC       (By similarity). Phosphorylated on Ser-60 by protein kinase C delta
CC       type catalytic subunit in a sphingosine-dependent fashion.
CC       {ECO:0000250, ECO:0000269|PubMed:9705322}.
CC   -!- PTM: Isoform Short contains a N-acetylmethionine at position 1.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the 14-3-3 family. {ECO:0000305}.
DR   EMBL; AF058797; AAC14343.1; -; mRNA.
DR   EMBL; AK002632; BAB22246.1; -; mRNA.
DR   EMBL; AK004872; BAB23631.1; -; mRNA.
DR   EMBL; AK011389; BAB27587.1; -; mRNA.
DR   EMBL; AK083367; BAC38886.1; -; mRNA.
DR   EMBL; AK144061; BAE25678.1; -; mRNA.
DR   EMBL; AK150414; BAE29538.1; -; mRNA.
DR   EMBL; AK151294; BAE30278.1; -; mRNA.
DR   EMBL; AK158932; BAE34730.1; -; mRNA.
DR   CCDS; CCDS17019.1; -. [Q9CQV8-1]
DR   RefSeq; NP_061223.2; NM_018753.6. [Q9CQV8-1]
DR   RefSeq; XP_006499972.1; XM_006499909.1. [Q9CQV8-1]
DR   PDB; 4GNT; X-ray; 2.41 A; A=1-239.
DR   PDB; 5F74; X-ray; 2.35 A; A=1-246.
DR   PDB; 5WFU; X-ray; 1.97 A; A/B/C/D=1-246.
DR   PDB; 5WFX; X-ray; 1.65 A; A/B=1-246.
DR   PDBsum; 4GNT; -.
DR   PDBsum; 5F74; -.
DR   PDBsum; 5WFU; -.
DR   PDBsum; 5WFX; -.
DR   SMR; Q9CQV8; -.
DR   BioGrid; 207648; 32.
DR   IntAct; Q9CQV8; 635.
DR   MINT; Q9CQV8; -.
DR   STRING; 10090.ENSMUSP00000018470; -.
DR   iPTMnet; Q9CQV8; -.
DR   PhosphoSitePlus; Q9CQV8; -.
DR   SwissPalm; Q9CQV8; -.
DR   UCD-2DPAGE; Q9CQV8; -.
DR   jPOST; Q9CQV8; -.
DR   PaxDb; Q9CQV8; -.
DR   PeptideAtlas; Q9CQV8; -.
DR   PRIDE; Q9CQV8; -.
DR   TopDownProteomics; Q9CQV8-1; -. [Q9CQV8-1]
DR   Ensembl; ENSMUST00000018470; ENSMUSP00000018470; ENSMUSG00000018326. [Q9CQV8-1]
DR   GeneID; 54401; -.
DR   KEGG; mmu:54401; -.
DR   UCSC; uc008ntp.1; mouse. [Q9CQV8-1]
DR   CTD; 7529; -.
DR   MGI; MGI:1891917; Ywhab.
DR   eggNOG; KOG0841; Eukaryota.
DR   eggNOG; COG5040; LUCA.
DR   GeneTree; ENSGT00950000182620; -.
DR   HOGENOM; HOG000240379; -.
DR   InParanoid; Q9CQV8; -.
DR   KO; K16197; -.
DR   OMA; KKQQMGR; -.
DR   OrthoDB; 1176818at2759; -.
DR   PhylomeDB; Q9CQV8; -.
DR   TreeFam; TF102003; -.
DR   Reactome; R-MMU-111447; Activation of BAD and translocation to mitochondria.
DR   Reactome; R-MMU-1445148; Translocation of SLC2A4 (GLUT4) to the plasma membrane.
DR   Reactome; R-MMU-165159; mTOR signalling.
DR   Reactome; R-MMU-166208; mTORC1-mediated signalling.
DR   Reactome; R-MMU-2028269; Signaling by Hippo.
DR   Reactome; R-MMU-392517; Rap1 signalling.
DR   Reactome; R-MMU-450385; Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA.
DR   Reactome; R-MMU-5625740; RHO GTPases activate PKNs.
DR   Reactome; R-MMU-5628897; TP53 Regulates Metabolic Genes.
DR   Reactome; R-MMU-5673000; RAF activation.
DR   Reactome; R-MMU-5674135; MAP2K and MAPK activation.
DR   Reactome; R-MMU-5675221; Negative regulation of MAPK pathway.
DR   Reactome; R-MMU-75035; Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex.
DR   Reactome; R-MMU-9614399; Regulation of localization of FOXO transcription factors.
DR   ChiTaRS; Ywhab; mouse.
DR   PRO; PR:Q9CQV8; -.
DR   Proteomes; UP000000589; Chromosome 2.
DR   Bgee; ENSMUSG00000018326; Expressed in 303 organ(s), highest expression level in substantia nigra.
DR   ExpressionAtlas; Q9CQV8; baseline and differential.
DR   Genevisible; Q9CQV8; MM.
DR   GO; GO:0005737; C:cytoplasm; ISO:MGI.
DR   GO; GO:0005829; C:cytosol; ISO:MGI.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; ISO:MGI.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISO:MGI.
DR   GO; GO:0032991; C:protein-containing complex; ISO:MGI.
DR   GO; GO:0017053; C:transcriptional repressor complex; ISO:MGI.
DR   GO; GO:0019899; F:enzyme binding; ISO:MGI.
DR   GO; GO:0042826; F:histone deacetylase binding; ISO:MGI.
DR   GO; GO:0042802; F:identical protein binding; ISO:MGI.
DR   GO; GO:0051219; F:phosphoprotein binding; ISO:MGI.
DR   GO; GO:0050815; F:phosphoserine residue binding; ISO:MGI.
DR   GO; GO:0008022; F:protein C-terminus binding; ISO:MGI.
DR   GO; GO:0019904; F:protein domain specific binding; IDA:MGI.
DR   GO; GO:0044877; F:protein-containing complex binding; ISO:MGI.
DR   GO; GO:0051220; P:cytoplasmic sequestering of protein; ISO:MGI.
DR   GO; GO:0045744; P:negative regulation of G protein-coupled receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0035308; P:negative regulation of protein dephosphorylation; ISO:MGI.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; ISO:MGI.
DR   GO; GO:0043085; P:positive regulation of catalytic activity; ISO:MGI.
DR   GO; GO:0051291; P:protein heterooligomerization; ISO:MGI.
DR   GO; GO:0006605; P:protein targeting; IDA:MGI.
DR   Gene3D; 1.20.190.20; -; 1.
DR   InterPro; IPR000308; 14-3-3.
DR   InterPro; IPR023409; 14-3-3_CS.
DR   InterPro; IPR036815; 14-3-3_dom_sf.
DR   InterPro; IPR023410; 14-3-3_domain.
DR   PANTHER; PTHR18860; PTHR18860; 1.
DR   Pfam; PF00244; 14-3-3; 1.
DR   PIRSF; PIRSF000868; 14-3-3; 1.
DR   PRINTS; PR00305; 1433ZETA.
DR   SMART; SM00101; 14_3_3; 1.
DR   SUPFAM; SSF48445; SSF48445; 1.
DR   PROSITE; PS00796; 1433_1; 1.
DR   PROSITE; PS00797; 1433_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative initiation; Complete proteome;
KW   Cytoplasm; Direct protein sequencing; Isopeptide bond; Nitration;
KW   Phosphoprotein; Reference proteome; Ubl conjugation.
FT   CHAIN           1..246
FT                   /note="14-3-3 protein beta/alpha"
FT                   /id="PRO_0000367902"
FT   INIT_MET        1
FT                   /note="Removed; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P31946"
FT   CHAIN           2..246
FT                   /note="14-3-3 protein beta/alpha, N-terminally processed"
FT                   /id="PRO_0000000005"
FT   SITE            58
FT                   /note="Interaction with phosphoserine on interacting
FT                   protein"
FT                   /evidence="ECO:0000250"
FT   SITE            129
FT                   /note="Interaction with phosphoserine on interacting
FT                   protein"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000250|UniProtKB:P31946"
FT   MOD_RES         2
FT                   /note="N-acetylthreonine; in 14-3-3 protein beta/alpha, N-
FT                   terminally processed"
FT                   /evidence="ECO:0000250|UniProtKB:P31946"
FT   MOD_RES         2
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P31946"
FT   MOD_RES         5
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P27348"
FT   MOD_RES         51
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P27348"
FT   MOD_RES         60
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:9705322"
FT   MOD_RES         70
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P31946"
FT   MOD_RES         84
FT                   /note="Nitrated tyrosine"
FT                   /evidence="ECO:0000244|PubMed:16800626"
FT   MOD_RES         106
FT                   /note="Nitrated tyrosine"
FT                   /evidence="ECO:0000244|PubMed:16800626"
FT   MOD_RES         117
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P31946"
FT   MOD_RES         186
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P68251"
FT   MOD_RES         232
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P31946"
FT   CROSSLNK        51
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P27348"
FT   VAR_SEQ         1..2
FT                   /note="Missing (in isoform Short)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_018634"
FT   CONFLICT        10
FT                   /note="Q -> H (in Ref. 1; AAC14343)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        74
FT                   /note="N -> D (in Ref. 1; AAC14343)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        126
FT                   /note="D -> Y (in Ref. 2; BAE29538/BAE30278)"
FT                   /evidence="ECO:0000305"
FT   HELIX           5..17
FT                   /evidence="ECO:0000244|PDB:5WFX"
FT   HELIX           21..33
FT                   /evidence="ECO:0000244|PDB:5WFX"
FT   HELIX           40..68
FT                   /evidence="ECO:0000244|PDB:5WFX"
FT   HELIX           75..105
FT                   /evidence="ECO:0000244|PDB:5WFX"
FT   HELIX           107..110
FT                   /evidence="ECO:0000244|PDB:5WFX"
FT   HELIX           114..134
FT                   /evidence="ECO:0000244|PDB:5WFX"
FT   HELIX           137..161
FT                   /evidence="ECO:0000244|PDB:5WFX"
FT   HELIX           167..182
FT                   /evidence="ECO:0000244|PDB:5WFX"
FT   HELIX           187..202
FT                   /evidence="ECO:0000244|PDB:5WFX"
FT   HELIX           203..207
FT                   /evidence="ECO:0000244|PDB:5WFX"
FT   TURN            210..212
FT                   /evidence="ECO:0000244|PDB:5WFX"
FT   HELIX           213..232
FT                   /evidence="ECO:0000244|PDB:5WFX"
**
**   #################    INTERNAL SECTION    ##################
**EV ECO:0000244; PDB:5WFX; INT; 16-JUL-2018.
**EV ECO:0000244; PubMed:16800626; 001; 16-JUL-2018.
**EV ECO:0000250; -; XXX; 16-JUL-2018.
**EV ECO:0000250; UniProtKB:P27348; 001; 16-JUL-2018.
**EV ECO:0000250; UniProtKB:P31946; 001; 16-JUL-2018.
**EV ECO:0000250; UniProtKB:P68251; 001; 16-JUL-2018.
**EV ECO:0000269; PubMed:15883195; BER; 03-MAY-2017.
**EV ECO:0000269; PubMed:18604201; UHI; 03-MAY-2017.
**EV ECO:0000269; PubMed:20478393; UHI; 03-MAY-2017.
**EV ECO:0000269; PubMed:26047703; UHI; 03-MAY-2017.
**EV ECO:0000269; PubMed:9705322; XXX; 16-JUL-2018.
**EV ECO:0000305; -; XXX; 16-JUL-2018.
**SO UPD; 20141; 17-APR-2007.
**SO UPD; 38830; 26-JAN-2009.
**SO UPD; 62097; 29-AUG-2011.
**SO UPD; 74185; 10-JAN-2013.
**ZB ALB, 01-NOV-2005; MCB, 12-MAY-2006; ALG/LYG, 14-AUG-2006; LYG, 15-DEC-2006;
**ZB LYG, 15-DEC-2006; MAM, 09-MAY-2007; JAJ, 15-JAN-2008; ANN, 19-FEB-2009;
**ZB ALG/EMB, 17-SEP-2009; ALB/EMB, 16-OCT-2009; SHS, 19-MAR-2010;
**ZB SIB, 02-NOV-2010; UHI, 06-APR-2011; CLD, 29-APR-2011; ANN, 01-NOV-2011;
**ZB SHS, 10-NOV-2011; DLI, 14-NOV-2011; SHS, 14-JAN-2013; ANS, 06-JUN-2014;
**ZB UHI, 31-MAR-2016; ANN, 19-APR-2016; SHS, 23-MAY-2016; ANS, 13-SEP-2016;
**ZB LIF, 28-NOV-2016; ANS, 12-APR-2017;
SQ   SEQUENCE   246 AA;  28086 MW;  51C366ED85B38EED CRC64;
     MTMDKSELVQ KAKLAEQAER YDDMAAAMKA VTEQGHELSN EERNLLSVAY KNVVGARRSS
     WRVISSIEQK TERNEKKQQM GKEYREKIEA ELQDICNDVL ELLDKYLILN ATQAESKVFY
     LKMKGDYFRY LSEVASGENK QTTVSNSQQA YQEAFEISKK EMQPTHPIRL GLALNFSVFY
     YEILNSPEKA CSLAKTAFDE AIAELDTLNE ESYKDSTLIM QLLRDNLTLW TSENQGDEGD
     AGEGEN
//
